CoChat

Modulation by general anaesthetics of rat GABAA receptors comprised of α 1 β 3 and β 3 subunits expressed in human embryonic kidney 293 cells

Open access
Davies, Paul A, Kirkness, Ewen F, Hales, Tim G · 1997 · British Journal of Pharmacology
Cited by 97

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Radioligand binding and patch‐clamp techniques were used to study the actions of γ‐aminobutyric acid (GABA) and the general anaesthetics propofol (2,6‐diisopropylphenol), pentobarbitone and 5α‐pregnan‐3α‐ol‐20‐one on rat α1 and β3 GABA A receptor subunits, expressed either alone or in combination. Membranes from HEK293 cells after transfection with α1 cDNA did not bind significant levels of [35 S]‐tert‐butyl bicyclophosphorothionate ([35 S]‐TBPS) (<0.03 pmol mg−1 protein). GABA (100 μ m) applied to whole‐cells transfected with α1 cDNA and clamped at −60 mV, also failed to activate discernible currents. The membranes of cells expressing β3 cDNAs bound [35 S]‐TBPS (∼1 pmol mg−1 protein). However, the binding was not influenced by GABA (10 n m–100 μ m). Neither GABA (100 μ m) nor picrotoxin (10 μ m) affected currents recorded from cells expressing β3 cDNA, suggesting that β3 subunits do not form functional GABA A receptors or spontaneously active ion channels. GABA (10 n m–100 μ m) modulated [35 S]‐TBPS binding to the membranes of cells transfected with both α1 and β3 cDNAs. GABA (0.1 μ m–1 m m) also dose‐dependently activated inward currents with an EC 50 of 9 μ m recorded from cells transfected with α1 and β3 cDNAs, clamped at −60 mV. Propofol (10 n m–100 μ m), pentobarbitone (10 n m–100 μ m) and 5α‐pregnan‐3α‐ol‐20‐one (1 n m–30 μ m) modulated [35 S]‐TBPS binding to the membranes of cells expressing either α1β3 or β3 receptors. Propofol (100 μ m), pentobarbitone (1 m m) and 5α‐pregnan‐3α‐ol‐20‐one (10 μ m) also activated currents recorded from cells expressing α1β3 receptors. Propofol (1 μ m–1 m m) and pentobarbitone (1 m m) both activated currents recorded from cells expressing β3 homomers. In contrast, application of 5α‐pregnan‐3α‐ol‐20‐one (10 μ m) failed to activate detectable currents. Propofol (100 μ m)‐activated currents recorded from cells expressing either α1β3 or β3 receptors reversed at the C1− equilibrium potential and were inhibited to 34±13% and 39±10% of control, respectively, by picrotoxin (10 μ m). 5α‐Pregnan‐3α‐ol‐20‐one (100 n m) enhanced propofol (100 μ m)‐evoked currents mediated by α1β3 receptors to 1101±299% of control. In contrast, even at high concentration 5α‐pregnan‐3α‐ol‐20‐one (10 μ m) caused only a modest facilitation (to 128±12% of control) of propofol (100 μ m)‐evoked currents mediated by β3 homomers. Propofol (3–100 μ m) activated α1β3 and β3 receptors in a concentration‐dependent manner. For both receptor combinations, higher concentrations of propofol (300 μ m and 1 m m) caused a decline in current amplitude. This inhibition of receptor function reversed rapidly during washout resulting in a ‘surge’ current on cessation of propofol (300 μ m and 1 m m) application. Surge currents were also evident following pentobarbitone (1 m m) application to cells expressing either receptor combination. By contrast, this phenomenon was not apparent following applications of 5α‐pregnan‐3α‐ol‐20‐one (10 μ m) to cells expressing α1β3 receptors. These observations demonstrate that rat β3 subunits form homomeric receptors that are not spontaneously active, are insensitive to GABA and can be activated by some general anaesthetics. Taken together, these data also suggest similar sites on GABA A receptors for propofol and barbiturates, and a separate site for the anaesthetic steroids. British Journal of Pharmacology (1997) 120, 899–909; doi:10.1038/sj.bjp.0700987

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0700987

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

Metadata

Authors
Davies, P. A., Kirkness, E. F., & Hales, T. G.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
1997-02
Volume
120
Issue
5
Pages
899-909
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2051919399
Cited by
97
References
2
FWCI
3.55
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.